{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:36:56Z","timestamp":1764139016313,"version":"3.46.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>This case report describes a young male patient admitted due to worsening of heart failure with recurrent embolic events. He had previously been diagnosed with hypertrophic cardiomyopathy (HCM) and left ventricular systolic dysfunction at other hospitals and was treated irregularly with medications including a beta-blocker and diuretics. On this admission, echocardiography and cardiac MR examination revealed left ventricular myocardial non-compaction combined with HCM. The coexistence of left ventricular hypertrophy and hypertrabeculation is rare, and the diagnosis has been updated according to the newly issued European Society of Cardiology guidelines. The present report describes the clinical features, therapy, and outcome of this disease.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1708374","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:34:07Z","timestamp":1764138847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hypertrophic cardiomyopathy meets left ventricular hypertrabeculation: from mixed cardiomyopathy to hypertrophic cardiomyopathy with hypertrabeculation"],"prefix":"10.3389","volume":"12","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/eurheartj\/ehac718","article-title":"Hypertrophic cardiomyopathy and left ventricular non-compaction cardiomyopathy: two in one","volume":"44","author":"Gabra","year":"2023","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"ytaf051","DOI":"10.1093\/ehjcr\/ytaf051","article-title":"A case report of mixed left ventricular non-compaction\/hypertrophic cardiomyopathy phenotype in a child","volume":"9","author":"Cirillo","year":"2025","journal-title":"Eur Heart J Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.21037\/qims-21-730","article-title":"Coexistence of hypertrophic cardiomyopathy and left ventricular non-compaction cardiomyopathy\u2014a description of two cases","volume":"12","author":"Kochanska","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa109","article-title":"Rare association of left ventricular non-compaction and hypertrophic cardiomyopathy","volume":"4","author":"Hotta","year":"2020","journal-title":"Eur Heart J Case Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.18087\/cardio.2020.4.n728","article-title":"Overlapping phenotype: left ventricular non-compaction and hypertrophic cardiomyopathy","volume":"60","author":"Komissarova","year":"2020","journal-title":"Kardiologiia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5603\/Cj.2022.0020","article-title":"One genotype, two phenotype: hypertrophic cardiomyopathy with left ventricular non-compaction","volume":"29","author":"Goncalves","year":"2022","journal-title":"Cardiol J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2021.10.013","article-title":"Sport practice in hypertrophic cardiomyopathy: running to stand still?","volume":"345","author":"Mascia","year":"2021","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/jcm13082343","article-title":"Detraining among athletes\u2014is withdrawal of adaptive cardiovascular changes a hint for the differential diagnosis of physically active people?","author":"Zujko-Kowalska","year":"2024","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.3390\/ijerph19084829","article-title":"Diagnostic yield of cardiac magnetic resonance in athletes with and without features of the athlete\u2019s heart and suspected structural heart disease","volume":"19","author":"Malek","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44348-025-00052-7","article-title":"Cardiac myosin inhibitors in hypertrophic cardiomyopathy","volume":"33","author":"Lim","year":"2025","journal-title":"J Cardiovasc Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e077274","DOI":"10.1136\/bmj-2023-077274","article-title":"Current management of hypertrophic cardiomyopathy","volume":"389","author":"Sikand","year":"2025","journal-title":"Br Med J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1708374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:34:12Z","timestamp":1764138852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1708374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":14,"alternative-id":["10.3389\/fcvm.2025.1708374"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1708374","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1708374"}}